Biotech
Major bio firm Alteogen seeks KOSPI listing
Riportato dall'IA Immagine generata dall'IA
Alteogen, the top market cap company on South Korea's secondary KOSDAQ market, has decided to move to the main KOSPI bourse to secure stable funding and enhance its corporate value. Shareholders approved the proposal on Monday, with the firm aiming for a listing next year.
Gestala, a new entrant in China's expanding brain-computer interface sector, aims to connect with the brain using ultrasound technology without needing implants. This approach highlights the industry's shift toward less invasive methods. The company emerges amid rapid growth in Chinese biotech innovation.
Riportato dall'IA
Nobel Prize-winning scientist Jennifer Doudna has cofounded Aurora Therapeutics, a startup focused on developing personalized gene-editing treatments for rare diseases. The company plans to leverage CRISPR technology and a new FDA regulatory pathway to bring these therapies to market. This initiative builds on recent successes in custom treatments that have saved lives.
A new treatment tested in brain organoids with glioblastoma outperformed chemotherapy and dramatically reduced tumors in mice. Human trials are upcoming. The approach also explores stem cell stimulation and aging cell rejuvenation for broader immunotherapy applications.
Riportato dall'IA
Summit's new drug for lung cancer demonstrated promising results in recent assessments. This development is part of ongoing biotech advancements in oncology. It was reported alongside other health innovations.